Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 294 results for "Pradaxa Lawsuits"

Drugmaker Takeda may settle Actos suits for $2.2 billion
Japan Times

Boehringer Ingelheim seeks FDA approval for Pradaxa to treat D...

Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that Pradaxa's maker, Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for its blood thinner to treat DVT and PE. According to PBR, Boehringer submitted a ... News-Medical.Net, 2 weeks ago
[x]  

Xarelto News Update: New Court Documents Issued in Two Courts, Says Lawsuitsettlementnews.com

/PRNewswire/ --MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that two new court documents have been issued in consolidated litigations over Xarelto in Louisiana and ...
 Wall Street Business Network1 month ago GranuFlo and NaturaLyte Bellwether Trials to Start in January of 2016, Says Lawsuitsettlementnews.com  Sys-Con Media1 month ago
[x]  

Law Firm Starts Two Suits for Deaths of Users of Xarelto

/PRNewswire/ -- The New York City law firm of this week commenced two wrongful death lawsuits, each involving the death of a user of the blood thinner Xarelto. In each case it is alleged that the drug is misleadingly marketed as a "one size fits ...
 Freshnews.com2 weeks ago
[x]  

Breckenridge files ANDA with Paragraph IV certification for generic version of Boehringer's Pradaxa

US-based Breckenridge Pharmaceutical has filed an abbreviated new drug application (ANDA) with a Paragraph IV certification for dabigatran etexilate mesylate capsules EQ 75mg and EQ 150mg strengths, which is a generic version of Boehringer ...
 Pharmaceutical Business Review1 month ago Breckenridge Pharmaceutical Updates on Paragraph IV ANDA Litigation with Boehringer Ingelheim for Its ANDA Dabigatran Etexilate Mesylate Capsules... [Manufacturing Close - Up]  Pharmacy Choice1 month ago Breckenridge Pharmaceutical Reports on Paragraph IV ANDA Litigation with Boehringer Ingelheim for Its ANDA Dabigatran Etexilate Mesylate Capsules... [Health & Beauty Close - Up]  Pharmacy Choice1 month ago Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation with Boehringer Ingelheim for its ANDA Dabigatran Etexilate Mesylate Capsules (Pradaxa┬«)  Franklin Credit Management Corporation1 month ago
[x]  
Pharmafocus

Boehringer takes pole position with its 'breakthrough' anti-anticoagulant

Boehringer Ingelheimsubmitted U.S., European and Canadian applications for an antidote to its own Pradaxa, leading the way among companies developing treatments that reverse the effects of blockbuster next-generation anticoagulants. The drug, ...
 FierceBiotech2 months ago Boehringer chases approval for anti-Pradaxa drug  Pharmafocus2 months ago

Xarelto Litigation Update Jacksonville Filing

Brenda S. Fulmer, a 21-year veteran of drug and medical device litigation and a partner with Searcy Denney, filed an indivdual lawsuit against the manufacturers of Xarelto in federal court in Jacksonvillle this week. The case is a wrongful death ...
 JD Supra1 week ago
Inside Counsel

Action is needed to confront spoliation creep

Inside counsel often feel like they have no choice but to pay the high premium of over preservation The first article in this series considered how the historic and universal principles of fair play that are the bedrock of the spoliation doctrine ...
 Inside Counsel2 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less